131 related articles for article (PubMed ID: 35477750)
1. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Zhang S; Nguyen LH; Zhou K; Tu HC; Sehgal A; Nassour I; Li L; Gopal P; Goodman J; Singal AG; Yopp A; Zhang Y; Siegwart DJ; Zhu H
Gastroenterology; 2018 Apr; 154(5):1421-1434. PubMed ID: 29274368
[TBL] [Abstract][Full Text] [Related]
3. Anillin is required for tumor growth and regulated by miR-15a/miR-16-1 in HBV-related hepatocellular carcinoma.
Lian YF; Huang YL; Wang JL; Deng MH; Xia TL; Zeng MS; Chen MS; Wang HB; Huang YH
Aging (Albany NY); 2018 Aug; 10(8):1884-1901. PubMed ID: 30103211
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma.
Zhang LH; Wang D; Li Z; Wang G; Chen DB; Cheng Q; Hu SH; Zhu JY
Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):337-344. PubMed ID: 32933876
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
6. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
[TBL] [Abstract][Full Text] [Related]
7. Actin-binding protein anillin promotes the progression of hepatocellular carcinoma
Jia H; Gao Z; Yu F; Guo H; Li B
Exp Ther Med; 2021 May; 21(5):454. PubMed ID: 33747188
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity.
Zhang X; Li L; Huang S; Liao W; Li J; Huang Z; Huang Y; Lian Y
Oxid Med Cell Longev; 2022; 2022():5322929. PubMed ID: 35340220
[TBL] [Abstract][Full Text] [Related]
9. Anillin governs mitotic rounding during early epidermal development.
Mahly A; Padmanabhan K; Soffer A; Cohen J; Omar J; Sagi-Eisenberg R; Luxenburg C
BMC Biol; 2022 Jun; 20(1):145. PubMed ID: 35710398
[TBL] [Abstract][Full Text] [Related]
10. Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury.
Lin YH; Zhang S; Zhu M; Lu T; Chen K; Wen Z; Wang S; Xiao G; Luo D; Jia Y; Li L; MacConmara M; Hoshida Y; Singal AG; Yopp A; Wang T; Zhu H
Gastroenterology; 2020 May; 158(6):1698-1712.e14. PubMed ID: 31972235
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer.
Zhou W; Wang Z; Shen N; Pi W; Jiang W; Huang J; Hu Y; Li X; Sun L
Mol Cell Biochem; 2015 Jan; 398(1-2):11-9. PubMed ID: 25223638
[TBL] [Abstract][Full Text] [Related]
12. Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.
Cao YF; Xie L; Tong BB; Chu MY; Shi WQ; Li X; He JZ; Wang SH; Wu ZY; Deng DX; Zheng YQ; Li ZM; Xu XE; Liao LD; Cheng YW; Li LY; Xu LY; Li EM
Cell Death Differ; 2023 Feb; 30(2):527-543. PubMed ID: 36526897
[TBL] [Abstract][Full Text] [Related]
13. The Polyploid State Plays a Tumor-Suppressive Role in the Liver.
Zhang S; Zhou K; Luo X; Li L; Tu HC; Sehgal A; Nguyen LH; Zhang Y; Gopal P; Tarlow BD; Siegwart DJ; Zhu H
Dev Cell; 2018 Feb; 44(4):447-459.e5. PubMed ID: 29429824
[TBL] [Abstract][Full Text] [Related]
14. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
15. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
[TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.
Studach LL; Rakotomalala L; Wang WH; Hullinger RL; Cairo S; Buendia MA; Andrisani OM
Hepatology; 2009 Aug; 50(2):414-23. PubMed ID: 19472310
[TBL] [Abstract][Full Text] [Related]
17. N
Zheng H; Cheng ZJ; Liang B; Wang ZG; Tao YP; Huang SY; Ni JS; Li HF; Yang L; Yuan SX; Wu J; Kawaguchi T; Samant H; Zhou WP; Xiang DM; Yang Y
Int J Biol Sci; 2023; 19(4):1009-1023. PubMed ID: 36923927
[TBL] [Abstract][Full Text] [Related]
18. Actin-binding protein Anillin promotes the progression of gastric cancer in vitro and in mice.
Jia H; Yu F; Li B; Gao Z
J Clin Lab Anal; 2021 Feb; 35(2):e23635. PubMed ID: 33089886
[TBL] [Abstract][Full Text] [Related]
19. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.
Xia W; Ni J; Zhuang J; Qian L; Wang P; Wang J
Int J Biochem Cell Biol; 2016 Feb; 71():1-11. PubMed ID: 26646106
[TBL] [Abstract][Full Text] [Related]
20. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
